CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2026

Neutral
AI Analysis

Summary

Ipsen reports aggregated share buy-back activity for week 30 of 2026 under MAR Article 5 disclosure requirements.

Importance:1/10
Sentiment:
0.00
share-buybackregulatory-disclosure
Related Companies

Read the original article

Published by GlobeNewswire Pharma on July 27, 2026 4:00 PM

Read Original